FIELD: pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics and discloses valerian extract for the treatment of GABAa-related disorders, wherein the ratio of valerenic acid (VA) to acetoxyvalerenic acid (AVA) in the extract is at least 3:1. Besides, the methods of producing of said extract are opened, and also pharmaceutical composition based on it. Group of inventions provides valerian extract, more effective for treatment of GABAa-related disorders.
EFFECT: besides, the group of inventions provides reducing the typical side effects and intoxication.
19 cl, 5 dwg, 7 ex, 5 tbl
Authors
Dates
2016-09-10—Published
2013-03-13—Filed